Given the established positive correlation between elevated serum PCSK9 levels, SURF4 upregulation, and hyperlipidemia—particularly through SURF4-mediated hepatic lipoprotein packaging and subsequent metabolic inactivation—we measured serum PCSK9 levels. This evidence concerns the gene PCSK9 and hyperlipidemia.